Respected Board Member to Head Launch of New Products Incorporating Proprietary Droplet Technology in Liquid Biopsy, Genome Phasing and Single Cell Analysis BILLERICA, Mass. — June 29, 2016 — RainDance Technologies, Inc., a genomics company providing leading-edge digital droplet techn
Collaboration provides new amfAR Institute for HIV Cure Research with access to RainDance’s unified Next-Generation Sequencing and Digital PCR platform BILLERICA, Mass. — December 7, 2015 — RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of
Next Gen Dx Summit Booth #28 August 23-26, 2016 Washington, DC www.nextgenerationdx.com Circulating Tumor Cell Program: Wed., August 24th at 12:50pm (Lunch Provided) Sensitive Assays to Detect Mutant ESR1 in Plasma Circulating Tumor DNA from Breast Cancer Patient Samples
Abstract Minimal residual disease (MRD) in acute myelogenous leukemia (AML) is emerging as an independent risk factor for disease relapse and has significant potential to guide therapeutic decisions. However, current methods for detecting gene mutation-based MRD are limited by a lack
Abstract Targeted next-generation sequencing has become a critical tool for the interrogation of genomic events in myeloid malignancies. In this webinar, Dr. Eric Padron of the Moffitt Cancer Center, discussed his experience using the RainDance ThunderBolts Myeloid panel focusing on h
RainDance Technologies prides itself on its continued innovation and ability to deliver Digital Droplet-based solutions that fundamentally enhance the way researchers and scientists study cell-based and cell-free biomarkers in cancer, infectious disease and inherited disorders. We are
The HudsonAlpha Institute for Biotechnology has been named the latest RainDance Center of Excellence and is now a premier reference site and service provider for RainDance products. HudsonAlpha is a nonprofit research institute committed to improving human health and the quality of li
RainDance Technologies is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.